Masimo Current Ratio 2010-2024 | MASI
Current and historical current ratio for Masimo (MASI) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Masimo current ratio for the three months ending June 30, 2024 was 2.09.
| Masimo Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-06-30 | $1.14B | $0.55B | 2.09 |
| 2024-03-31 | $1.17B | $0.50B | 2.31 |
| 2023-12-31 | $1.23B | $0.56B | 2.19 |
| 2023-09-30 | $1.24B | $0.58B | 2.14 |
| 2023-06-30 | $1.21B | $0.57B | 2.11 |
| 2023-03-31 | $1.26B | $0.58B | 2.16 |
| 2022-12-31 | $1.31B | $0.63B | 2.08 |
| 2022-09-30 | $1.25B | $0.59B | 2.12 |
| 2022-06-30 | $1.16B | $0.55B | 2.10 |
| 2022-03-31 | $1.23B | $0.25B | 4.82 |
| 2021-12-31 | $1.24B | $0.27B | 4.63 |
| 2021-09-30 | $1.14B | $0.23B | 4.99 |
| 2021-06-30 | $1.05B | $0.22B | 4.78 |
| 2021-03-31 | $0.98B | $0.20B | 4.99 |
| 2020-12-31 | $1.10B | $0.23B | 4.71 |
| 2020-09-30 | $1.16B | $0.23B | 4.98 |
| 2020-06-30 | $1.09B | $0.23B | 4.80 |
| 2020-03-31 | $0.98B | $0.16B | 6.23 |
| 2019-12-31 | $1.00B | $0.17B | 5.78 |
| 2019-09-30 | $0.93B | $0.15B | 6.23 |
| 2019-06-30 | $0.86B | $0.14B | 6.35 |
| 2019-03-31 | $0.85B | $0.12B | 7.02 |
| 2018-12-31 | $0.79B | $0.15B | 5.39 |
| 2018-09-30 | $0.74B | $0.14B | 5.12 |
| 2018-06-30 | $0.65B | $0.13B | 5.05 |
| 2018-03-31 | $0.60B | $0.13B | 4.55 |
| 2017-12-31 | $0.56B | $0.13B | 4.32 |
| 2017-09-30 | $0.55B | $0.17B | 3.17 |
| 2017-06-30 | $0.57B | $0.15B | 3.89 |
| 2017-03-31 | $0.56B | $0.20B | 2.75 |
| 2016-12-31 | $0.51B | $0.22B | 2.30 |
| 2016-09-30 | $0.33B | $0.14B | 2.25 |
| 2016-06-30 | $0.30B | $0.12B | 2.46 |
| 2016-03-31 | $0.32B | $0.12B | 2.65 |
| 2015-12-31 | $0.30B | $0.13B | 2.26 |
| 2015-09-30 | $0.30B | $0.11B | 2.66 |
| 2015-06-30 | $0.31B | $0.11B | 2.71 |
| 2015-03-31 | $0.32B | $0.12B | 2.69 |
| 2014-12-31 | $0.30B | $0.12B | 2.40 |
| 2014-09-30 | $0.30B | $0.24B | 1.25 |
| 2014-06-30 | $0.27B | $0.17B | 1.59 |
| 2014-03-31 | $0.29B | $0.10B | 2.96 |
| 2013-12-31 | $0.27B | $0.10B | 2.62 |
| 2013-09-30 | $0.26B | $0.10B | 2.53 |
| 2013-06-30 | $0.24B | $0.09B | 2.54 |
| 2013-03-31 | $0.23B | $0.10B | 2.37 |
| 2012-12-31 | $0.22B | $0.09B | 2.45 |
| 2012-09-30 | $0.26B | $0.08B | 3.08 |
| 2012-06-30 | $0.27B | $0.08B | 3.55 |
| 2012-03-31 | $0.27B | $0.09B | 2.98 |
| 2011-12-31 | $0.26B | $0.08B | 3.46 |
| 2011-09-30 | $0.28B | $0.07B | 4.19 |
| 2011-06-30 | $0.25B | $0.06B | 4.08 |
| 2011-03-31 | $0.23B | $0.06B | 3.67 |
| 2010-12-31 | $0.22B | $0.07B | 3.10 |
| 2010-09-30 | $0.25B | $0.07B | 3.55 |
| 2010-06-30 | $0.23B | $0.06B | 3.54 |
| 2010-03-31 | $0.22B | $0.07B | 3.01 |
| 2009-12-31 | $0.29B | $0.06B | 4.87 |
| 2009-09-30 | $0.28B | $0.06B | 4.87 |
| 2009-06-30 | $0.25B | $0.05B | 4.75 |
| 2009-03-31 | $0.24B | $0.06B | 4.02 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.481B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.021B | 27.33 |
| Intuitive Surgical (ISRG) | United States | $172.269B | 97.54 |
| Alcon (ALC) | Switzerland | $47.692B | 33.57 |
| IQVIA Holdings (IQV) | United States | $41.794B | 23.68 |
| Edwards Lifesciences (EW) | United States | $41.042B | 26.31 |
| IDEXX Laboratories (IDXX) | United States | $39.200B | 47.15 |
| DexCom (DXCM) | United States | $27.734B | 39.55 |
| STERIS (STE) | Ireland | $22.376B | 26.11 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.049B | 0.00 |
| Waters (WAT) | United States | $21.250B | 31.68 |
| Hologic (HOLX) | United States | $18.538B | 20.15 |
| Sysmex ADR (SSMXY) | Japan | $12.254B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.502B | 12.90 |
| Teleflex (TFX) | United States | $11.121B | 17.29 |
| Globus Medical (GMED) | United States | $9.556B | 26.73 |
| Penumbra (PEN) | United States | $7.893B | 81.93 |
| Glaukos (GKOS) | United States | $6.973B | 0.00 |
| TransMedics (TMDX) | United States | $4.510B | 193.13 |
| Integer Holdings (ITGR) | United States | $4.334B | 25.34 |
| PROCEPT BioRobotics (PRCT) | United States | $3.724B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.852B | 16.73 |
| Veracyte (VCYT) | United States | $2.613B | 162.00 |
| Elekta AB (EKTAY) | Sweden | $2.595B | 21.14 |
| Inari Medical (NARI) | United States | $2.436B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.427B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.246B | 13.98 |
| RxSight (RXST) | United States | $1.857B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.492B | 6.80 |
| Artivion (AORT) | United States | $1.086B | 99.69 |
| Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.037B | 18.50 |
| OPKO Health (OPK) | United States | $1.018B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.723B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.683B | 17.24 |
| AxoGen (AXGN) | United States | $0.645B | 0.00 |
| IRadimed (IRMD) | United States | $0.639B | 34.53 |
| OrthoPediatrics (KIDS) | United States | $0.596B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.595B | 0.00 |
| SiBone (SIBN) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
| Paragon 28 (FNA) | United States | $0.478B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 10.26 |
| Treace Medical Concepts (TMCI) | United States | $0.327B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.320B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.289B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.260B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.231B | 0.00 |
| Inogen (INGN) | United States | $0.213B | 0.00 |
| NeuroPace (NPCE) | United States | $0.193B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.192B | 13.46 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.153B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
| 908 Devices (MASS) | United States | $0.120B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.109B | 16.15 |
| EDAP TMS S.A (EDAP) | France | $0.097B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.063B | 0.00 |
| LENSAR (LNSR) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.042B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.038B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Neuronetics (STIM) | United States | $0.028B | 0.00 |
| Precision Optics (POCI) | United States | $0.027B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.026B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |